GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eastgate Biotech ETBI · USD

N/A · US listing · 🇺🇸 United States

Compare

0.01

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Eastgate Biotech — daily ETBI Delayed
Market value
$3.6m
Last close × shares
Volume
7.7m
Shares, 30 Oct 2026

About Eastgate Biotech

Its shares trade under the ticker ETBI. It has been listed since 16 January 2014. In the fiscal year to 31 December 2015, it reported revenue of $132,025 and a net loss of $4.3m. At that date it held total assets of $297,919 and shareholders' equity of −$2.5m.

Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. The company is headquartered in Salt Lake City, Utah. The company went IPO on 2014-01-16. The firm is primarily engaged in the development of formulations of natural compounds and pharmaceutical products. The firm produces and distributes healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. The firm offers EGP-1214, a compressed tablet containing human recombinant insulin that is designed for sublingual administration. The company offers a range of products, such as E-Drops, which is used to combat urinary and vaginal tract infections; Essential D, which is an enhanced Vitamin D3, working to improve the body's digestive, cardiovascular, and immune systems; Puralen, is an all-natural herbal cleanse of colon and the urinary tract; GluCora, which prevents fat deposition; VCleanzz, which is an antibacterial wash for fruits and vegetables; Cleanezze, which is a natural hand sanitizer, and Warts X, which is a natural herbal product that treats warts.

Figures and description from our data supplier, not checked against the company's own report.

More about Eastgate Biotech →

Latest on Eastgate Biotech

Our reporting

We have not reported on Eastgate Biotech yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Eastgate Biotech's ticker?

Eastgate Biotech trades as ETBI on its US listing, under ISIN US2772531008.

What was Eastgate Biotech's last closing price?

0.01 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.